Alnylam Pharmaceuticals Inc.

In News

Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook - Yahoo Finance

Yahoo Finance - Sep 20, 2026

Will RNAi Market Growth Change Alnylam Stock's Narrative? - simplywall.st

simplywall.st - Sep 20, 2026

Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress - Alnylam

Alnylam - Jul 30, 2026

Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial - TradingView

TradingView - Sep 20, 2026

Alnylam Pharmaceuticals Inc (WBO:ALNY) Stock Price, Trades & News - GuruFocus

GuruFocus - Sep 18, 2026

Alnylam plunges as earnings deliver ‘one-two punch’ - biopharmadive.com

biopharmadive.com - Jul 30, 2026

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics - Business Wire

Business Wire - Jun 03, 2026

Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial - Yahoo Finance

Yahoo Finance - Sep 20, 2026

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR - Alnylam

Alnylam - Aug 30, 2026

Alnylam Pharmaceuticals, Inc. RNAi Roundtable Call Transcript - GuruFocus

GuruFocus - Sep 17, 2026

Alnylam Pharmaceuticals (ALNY) Highlighted As An Oligonucleotide Therapeutics Leader Through 2035 - simplywall.st

simplywall.st - Sep 17, 2026

Here’s Why Alnylam Pharmaceuticals (ALNY) Declined - Yahoo Finance

Yahoo Finance - Sep 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment